Shinsuke Ogusu
Saga, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Pulmonary Involvement in ANCA-associated Vasculitis Overlapping with Long-standing Systemic Lupus Erythematosus.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance.
Journal: Anticancer research
Published: February 28, 2026
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study.
Journal: Translational lung cancer research
Published: February 20, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Toxocariasis presenting with peripheral eosinophilia and eosinophilic pleural effusion: A case report.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: January 31, 2026
Idiopathic Multicentric Castleman's Disease Diagnosed by Pulmonary Histopathology: A Case Report.
Journal: Respirology case reports
Published: December 10, 2025
A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non-Small Cell Lung Cancer With Cachexia (SPIRAL-ANA).
Journal: Journal of cachexia, sarcopenia and muscle
Published: November 20, 2025
Sarcoidosis with Trismus Caused by Acute, Progressive Swelling of the Parotid Glands.
Journal: Internal medicine (Tokyo, Japan)
Published: October 29, 2025
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102).
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 06, 2025
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.
Journal: International journal of clinical oncology
Published: May 05, 2025
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.
Journal: Clinical lung cancer
Published: April 30, 2025
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure.
Journal: Targeted oncology
Published: April 08, 2025
Last Updated: 09/26/2026